Cited by 442Chronic Kidney Disease and DiabetesLipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cholesterol and the risk of renal dysfunction in apparently healthy men

Schaeffner, Elke S., Kurth, Tobias, Curhan, Gary C., Glynn, Robert J., Rexrode, Kathryn M., Baigent, Colin, Buring, Julie E., Gaziano, J. Michael·2003·Journal of the American Society of Nephrology

Abstract

Despite extensive knowledge about abnormal lipid patterns in patients with end-stage renal disease, the association between cholesterol and the development of renal dysfunction is unclear. We evaluated this association in a prospective cohort study among 4,483 initially healthy men participating in the Physicians' Health Study who provided blood samples in 1982 and 1996. Main outcome measures were elevated creatinine, defined as >/= 1.5 mg/dl (133 micromol/L), and reduced estimated creatinine clearance, defined as /= 240 mg/dl), HDL ( /= 40 mg/dl), total non-HDL cholesterol, and the ratio of total cholesterol to HDL. We used logistic regression to calculate age- and multivariable adjusted odds ratios as a measure for the relative risk. After 14 yr, 134 men (3.0%) had elevated creatinine and 244 (5.4%) had reduced creatinine clearance. The multivariable relative risk for elevated creatinine was 1.77 (95% confidence interval [CI], 1.10 to 2.86) for total cholesterol >/= 240 mg/dl, 2.16 (95% CI, 1.42 to 3.27) for HDL /= >6.8), and 2.16 (95% CI, 1.22 to 3.80) for the highest quartile of non-HDL cholesterol (>/= 196.1). Similar although smaller associations were observed between cholesterol parameters and reduced creatinine clearance. Elevated total cholesterol, high non-HDL cholesterol, a high ratio of total cholesterol/HDL, and low HDL in particular were significantly associated with an increased risk of developing renal dysfunction in men with an initial creatinine <1.5 mg/dl.

Integrity signals

Registry

Crossref · 10.1681/asn.v1482084

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dyslipidemia is a risk factor for progressive kidney disease.

    “While dyslipidemia is a risk factor for progressive kidney disease (8,10,20,21)”

    From Effects of Fibrates in Kidney Disease (2012) · cites this paper as [20]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Schaeffner, E. S., Kurth, T., Curhan, G. C., Glynn, R. J., Rexrode, K. M., Baigent, C., Buring, J. E., & Gaziano, J. M.
Affiliations
Brigham and Women's Hospital (US)
Corresponding author
  • Kurth, Tobias
  • Glynn, Robert J.
  • Rexrode, Kathryn M.
  • Buring, Julie E.
  • Gaziano, J. Michael
Venue
Journal of the American Society of Nephrology
Published
2003-08
Volume
14
Issue
8
Pages
2084-2091
ISSN
1046-6673 (ISSN-L)
OpenAlex
W2120479558
Cited by
442
References
1
Citations by year
2026: 9 · 2025: 14 · 2024: 18 · 2023: 19 · 2022: 24 · 2021: 21 · 2020: 23 · 2019: 13 · 2018: 19 · 2017: 23 · 2016: 23 · 2015: 20 · 2014: 24 · 2013: 18 · 2012: 22
FWCI
11.35
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of the American Society of Nephrology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (R01CA097193)
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
cholesterol, renal dysfunction, HDL cholesterol, non-HDL cholesterol, TC/HDL-C ratio, creatinine elevation, end-stage renal disease, lipid metabolism, men, Physicians' Health Study
MeSH terms
Cholesterol, Creatinine, Edetic Acid, Glomerular Filtration Rate, Humans, Kidney Diseases, Kidney Failure, Chronic, Cholesterol, HDL, Male, Prospective Studies, Risk, Time Factors, Cohort Studies, Multivariate Analysis, Logistic Models, Odds Ratio, Treatment Outcome, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review